Ultragenyx: 2Q Earnings Snapshot
NOVATO, Calif. (AP) _ Ultragenyx Pharmaceutical Inc. (RARE) on Thursday reported a loss of $99.2 million in its second quarter.
On a per-share basis, the Novato, California-based company said it had a loss of $1.72. Losses, adjusted for non-recurring gains, were $1.85 per share.
The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.73 per share.
The biotechnology company posted revenue of $24.1 million in the period, exceeding Street forecasts. Eight analysts surveyed by Zacks expected $21.7 million.
Ultragenyx shares have increased 39% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $60.43, a drop of 24% in the last 12 months.